Refresh

Nectar Lifesciences Ltd. - Research Center

532649 NECLIFE Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

1,523.67 1,668.23 1,541.82 2,362.80 2,784.93
Expenses

Material consumed

1,187.41 1,252.41 1,187.49 1,891.93 2,236.97

Manufacturing expenses

143.94 116.26 96.74 104.60 137.29

Personnel expenses

77.78 74.55 73.37 81.00 79.90

Selling expenses

0.11 0.11 0.05 0.07 0.07

Adminstrative expenses

59.72 66.09 75.02 67.23 66.81

Expenses capitalised

- - - - -

Cost of sales

1,468.95 1,509.42 1,432.67 2,144.83 2,521.03

Operating profit

54.72 158.81 109.16 217.97 263.90

Other recurring income

43.18 11.32 3.79 4.36 6.04

Adjusted PBDIT

97.90 170.13 112.95 222.33 269.94

Financial expenses

79.48 78.81 112.03 125.82 148.13

Depreciation

59.12 56.97 60.25 60.77 63.26

Other write offs

- - - - -

Adjusted PBT

-40.69 34.35 -59.34 35.74 58.55

Tax charges

-18.24 9.03 -11.50 5.68 11.22

Adjusted PAT

-22.46 25.32 -47.83 30.06 47.33

Non recurring items

- - -25.32 - 0.03

Other non cash adjustments

- - - - -

Reported net profit

-22.46 25.32 -73.15 30.06 47.36

Earnigs before appropriation

695.25 717.31 693.12 767.62 740.66

Equity dividend

- - 1.12 0.89 1.35

Preference dividend

- - - - -

Dividend tax

- - - 0.23 -

Retained earnings

695.25 717.31 691.99 766.49 739.31
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com